Tamara A. Mamaeva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Tamara A. Mamaeva has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Nina T. Tikhonova
G.N. Gabrichevsky Research Institute for Epidemiology and Microbiology
6 shared publications - M. A. Nаumova
G.N. Gabrichevsky Research Institute for Epidemiology and Microbiology, WHO European Reference Laboratory for Measles and Rubella, Moscow, Russia
5 shared publications - Vladimir Aleshkin
Russian Academy of Medical Sciences
2 shared publications A G Gerasimova
1 shared publicationA I Starov
1 shared publicationA. G. Gerasimova
G. N. Gabrichevsky Institute of Epidemiology and Microbiology, Moscow, Russian Federation
1 shared publication
Latest Publications
- Open Access
- 7 November 2023
- Published by Central Research Institute for Epidemiology in Problems of Virology
- Vol. 68 (5) , 361-371
Global genetic diversity of measles virus (Paramyxoviridae: Morbillivirus: Morbillivirus hominis): historical aspects and current state
Monitoring the circulation of the measles virus and studying its genetic diversity is an important component of the measles elimination program. A methodological approach to molecular genetic studies and their interpretation in the measles surveillance was developed in the early 2000s. During its development, clear areas of circulation of each genotype of the virus were identified, therefore, the determination of viruses genotypes was proposed to monitor circulation and identify transmission pathways. However, in the future, due to a significant decrease in the number of active genotypes, an approach based on sub-genotyping was proposed: determining not only the genotype of the virus, but also its genetic lineage/genetic variant. The Global Measles and Rubella Laboratory Network (GMRLN) systematically monitors the circulation of the measles virus at the sub-genotypic level, depositing the results in a specialized database MeaNS2. It is this database that is the most complete and reliable source of information about the genetic characteristic of measles viruses. This review presents both historical information and the latest data on the global genetic diversity of the measles virus.
- 7 November 2023
- Published by Central Research Institute for Epidemiology in Problems of Virology
- Vol. 68 (5) , 361-371
Open AccessGlobal genetic diversity of measles virus (Paramyxoviridae: Morbillivirus: Morbillivirus hominis): historical aspects and current state
Monitoring the circulation of the measles virus and studying its genetic diversity is an important component of the measles elimination program. A methodological approach to molecular genetic studies and their interpretation in the measles surveillance was developed in the early 2000s. During its development, clear areas of circulation of each genotype of the virus were identified, therefore, the determination of viruses genotypes was proposed to monitor circulation and identify transmission pathways. However, in the future, due to a significant decrease in the number of active genotypes, an approach based on sub-genotyping was proposed: determining not only the genotype of the virus, but also its genetic lineage/genetic variant. The Global Measles and Rubella Laboratory Network (GMRLN) systematically monitors the circulation of the measles virus at the sub-genotypic level, depositing the results in a specialized database MeaNS2. It is this database that is the most complete and reliable source of information about the genetic characteristic of measles viruses. This review presents both historical information and the latest data on the global genetic diversity of the measles virus.
- Open Access
- 28 March 2017
- Published by SPb RAACI in Russian Journal of Infection and Immunity
- Vol. 7 (1) , 69-78
IMPROVEMENT OF THE QUALITY CONTROL OF ELISA TESTING FOR THE LABORATORY CONFIRMATION OF MEASLES AND RUBELLA INFECTIONS AT THE STAGE OF THE MEASLES/ RUBELLA ELIMINATION PROGRAM
Для оценки результатов серологических исследований по определению антител классов IgM и IgG к вирусам кори и краснухи методом ИФА в рамках программы элиминации этих инфекций в странах СНГ и России впервые на основании распоряжения Правительства Российской Федерации от 4 апреля 2014 г. №523-р были приготовлены внутренние лабораторные контроли (ВЛК): «Корь-IgM серия 1», «Корь-IgM серия 2», «Рубелла-IgM», «Корь-IgG», «Рубелла-IgG». Согласно паспортным данным, образцы ВЛК представляют собой лиофилизированную сыворотку крови человека, инактивированную прогреванием (56°C в течение 1 ч), стабилизированную с помощью смеси сахарозы (5%) и консерванта ProClin-3000. Препараты не содержат HBsAg, антител к ВГС, T. pallidum, ВИЧ-1/2, антиген р24 ВИЧ-1. Целью данного исследования явилась оценка возможности использования серий ВЛК при определении IgM и IgG к вирусам кори и краснухи методом ИФА в тест-системах, используемых лабораторной сетью по надзору за корью/краснухой в странах СНГ и России. При определении специфической активности ВЛК «Корь-IgM серия 1», «Корь-IgM серия 2», «Рубелла-IgM в тест-системах разного формата фирм (Вектор Бест, Эколаб, Siemens) получены статистически различимые результаты (р < 0,05). Показатели IgM, полученные при анализе контролей «Корь-IgM с.1» и «Корь-IgM с.2» с помощью «ВектоКорь IgM» были выше значений, полученных с использованием наборов IgEnzygnost®Anti-MeaslesVirus/IgМ: 1,33±0,02 о.е. против 0,18±0,01 о.е. при р < 0,05 и 2,83±0,03 о.е. против 0,7±0,02 о.е. при р < 0,05 соответственно. В образцах «Рубелла-IgМ» значения ОП IgM в наборах «ИФА-краснуха IgM» также превышали показатели, полученных с помощью IgEnzygnost®Anti-Rubella Virus/IgМ: 2,92±0,04 о.е. против 0,88±0,03 о.е. при р < 0,05. Определена статистическая достоверность и высокая информационная способность моделей зависимости изменений ОП от степени разведений исходного образца ВЛК при подборе параметров рабочих растворов ВЛК для тестов: «capture» и «indirect» формата: коэффициент детерминации (R2) составляет 97,34 и 99,29, значения критерия Фишера (F) — 219,62 и 556,55, и уровень значимости (р) — 0,000 (< 0,05) и 0,000 (< 0,05) соответственно. Рекомендуемые авторами оптимальные рабочие разведения IgM-содержащих образцов ВЛК позволяют исключить влияние нецелевых маркеров (IgG) и обеспечивают, с учетом формата используемой тест-системы, получение искомой величины показателя 2–3 «cut-off» специфического маркера. Кроме того, в работе обсуждается вопрос о количественном содержании целевого маркера в ВЛК и целесообразности проведения совместных с производителями исследований по определению качества наборов для определения специфических маркеров к вирусам кори и краснухи.
- 28 March 2017
- Published by SPb RAACI in Russian Journal of Infection and Immunity
- Vol. 7 (1) , 69-78
Open AccessIMPROVEMENT OF THE QUALITY CONTROL OF ELISA TESTING FOR THE LABORATORY CONFIRMATION OF MEASLES AND RUBELLA INFECTIONS AT THE STAGE OF THE MEASLES/ RUBELLA ELIMINATION PROGRAM
Для оценки результатов серологических исследований по определению антител классов IgM и IgG к вирусам кори и краснухи методом ИФА в рамках программы элиминации этих инфекций в странах СНГ и России впервые на основании распоряжения Правительства Российской Федерации от 4 апреля 2014 г. №523-р были приготовлены внутренние лабораторные контроли (ВЛК): «Корь-IgM серия 1», «Корь-IgM серия 2», «Рубелла-IgM», «Корь-IgG», «Рубелла-IgG». Согласно паспортным данным, образцы ВЛК представляют собой лиофилизированную сыворотку крови человека, инактивированную прогреванием (56°C в течение 1 ч), стабилизированную с помощью смеси сахарозы (5%) и консерванта ProClin-3000. Препараты не содержат HBsAg, антител к ВГС, T. pallidum, ВИЧ-1/2, антиген р24 ВИЧ-1. Целью данного исследования явилась оценка возможности использования серий ВЛК при определении IgM и IgG к вирусам кори и краснухи методом ИФА в тест-системах, используемых лабораторной сетью по надзору за корью/краснухой в странах СНГ и России. При определении специфической активности ВЛК «Корь-IgM серия 1», «Корь-IgM серия 2», «Рубелла-IgM в тест-системах разного формата фирм (Вектор Бест, Эколаб, Siemens) получены статистически различимые результаты (р < 0,05). Показатели IgM, полученные при анализе контролей «Корь-IgM с.1» и «Корь-IgM с.2» с помощью «ВектоКорь IgM» были выше значений, полученных с использованием наборов IgEnzygnost®Anti-MeaslesVirus/IgМ: 1,33±0,02 о.е. против 0,18±0,01 о.е. при р < 0,05 и 2,83±0,03 о.е. против 0,7±0,02 о.е. при р < 0,05 соответственно. В образцах «Рубелла-IgМ» значения ОП IgM в наборах «ИФА-краснуха IgM» также превышали показатели, полученных с помощью IgEnzygnost®Anti-Rubella Virus/IgМ: 2,92±0,04 о.е. против 0,88±0,03 о.е. при р < 0,05. Определена статистическая достоверность и высокая информационная способность моделей зависимости изменений ОП от степени разведений исходного образца ВЛК при подборе параметров рабочих растворов ВЛК для тестов: «capture» и «indirect» формата: коэффициент детерминации (R2) составляет 97,34 и 99,29, значения критерия Фишера (F) — 219,62 и 556,55, и уровень значимости (р) — 0,000 (< 0,05) и 0,000 (< 0,05) соответственно. Рекомендуемые авторами оптимальные рабочие разведения IgM-содержащих образцов ВЛК позволяют исключить влияние нецелевых маркеров (IgG) и обеспечивают, с учетом формата используемой тест-системы, получение искомой величины показателя 2–3 «cut-off» специфического маркера. Кроме того, в работе обсуждается вопрос о количественном содержании целевого маркера в ВЛК и целесообразности проведения совместных с производителями исследований по определению качества наборов для определения специфических маркеров к вирусам кори и краснухи.
- 8 October 2014
- No. 4,p. 49-53
[Epidemiologic control for rubella in pregnant women].
Evaluate effectiveness of measures specified by epidemiologic control for rubella in pregnant women. 585 pregnant women with suspected measles were laboratory examined in 10 Regional Centers of Control for Measles and Rubella by EIA. 24 rubella infected pregnant women aged 16-36 years were detected among the examined pregnant women, most of those (91.7%) were either not immunized against rubella or had unknown immunization anamnesis: 16 women terminated pregnancy, in 8 women pregnancy ended with delivery at term. Of the 8 newborns only a single child had innate rubella infection (the child was clinically healthy). Epidemiologic investigation of each rubella case in pregnant women with obligatory laboratory examination of women and source of infection revealed a significant number of women at childbearing age susceptible to rubella virus that retains the possibility of birth of children with innate rubella syndrome.
- 8 October 2014
- No. 4,p. 49-53
[Epidemiologic control for rubella in pregnant women].
Evaluate effectiveness of measures specified by epidemiologic control for rubella in pregnant women. 585 pregnant women with suspected measles were laboratory examined in 10 Regional Centers of Control for Measles and Rubella by EIA. 24 rubella infected pregnant women aged 16-36 years were detected among the examined pregnant women, most of those (91.7%) were either not immunized against rubella or had unknown immunization anamnesis: 16 women terminated pregnancy, in 8 women pregnancy ended with delivery at term. Of the 8 newborns only a single child had innate rubella infection (the child was clinically healthy). Epidemiologic investigation of each rubella case in pregnant women with obligatory laboratory examination of women and source of infection revealed a significant number of women at childbearing age susceptible to rubella virus that retains the possibility of birth of children with innate rubella syndrome.
- 20 December 2012
- Vol. 57 (5) , 21-6
[Peculiarity of the laboratory diagnostic of the measles virus infection in previously vaccinated and unvaccinated patients].
119 specimens of blood sera collected from measles cases with different vaccination history (aged 4 months to 48 years) on 5th-6th days after rash onset were Investigated using EIA. The obtained results showed that the primary immune response (PIR) was developed in 59 patients; the secondary immune response (SIR) was developed in 60 patients with a significant increase in the specific high avidity IgG (22.34 IU/ml +/- 3.2). The specific IgM were detected in 100% cases studied with capture ELISA in both previously vaccinated and unvaccinated individuals of different age. The specific IgM were detected by indirect ELISA in 100% cases in unvaccinated patients, while IgM positive sera was defined only in 23.3% of individuals with SIR. It was concluded that measles virus infection in previously vaccinated and unvaccinated adults had clinical differences. The role of patients with SIR in virus transmission was discussed.
- 20 December 2012
- Vol. 57 (5) , 21-6
[Peculiarity of the laboratory diagnostic of the measles virus infection in previously vaccinated and unvaccinated patients].
119 specimens of blood sera collected from measles cases with different vaccination history (aged 4 months to 48 years) on 5th-6th days after rash onset were Investigated using EIA. The obtained results showed that the primary immune response (PIR) was developed in 59 patients; the secondary immune response (SIR) was developed in 60 patients with a significant increase in the specific high avidity IgG (22.34 IU/ml +/- 3.2). The specific IgM were detected in 100% cases studied with capture ELISA in both previously vaccinated and unvaccinated individuals of different age. The specific IgM were detected by indirect ELISA in 100% cases in unvaccinated patients, while IgM positive sera was defined only in 23.3% of individuals with SIR. It was concluded that measles virus infection in previously vaccinated and unvaccinated adults had clinical differences. The role of patients with SIR in virus transmission was discussed.
- 6 April 2010
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 139 (2) , 239-246
Enhanced surveillance for measles in low-incidence territories of the Russian Federation: defining a rate for suspected case investigation
SUMMARY The rate of case investigation for measles-like illness (MLI) is an important indicator for the quality of measles surveillance in countries targeting measles elimination. However, a benchmark rate is still being discussed. We assessed different rates of investigation in 11 territories of the Russian Federation with low reported measles incidence during the previous 4–7 years. Each territory maintained their existing surveillance activities and also undertook additional surveillance activities for MLI over a 3-year period. The annual routine rate of investigation varied from 0·06 to 1·8/100 000 population; the overall rate of investigation, including enhanced surveillance, varied from 1·4 to 7·2/100 000. Forty-nine (30·8%) of 159 measles cases detected were identified through enhanced surveillance. Based on the results of this study, the Russian Federation concluded that a rate of routine investigation of 2/100 000 provided the best balance between available resources and sensitivity for detection of measles cases.
- 6 April 2010
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 139 (2) , 239-246
Enhanced surveillance for measles in low-incidence territories of the Russian Federation: defining a rate for suspected case investigation
SUMMARY The rate of case investigation for measles-like illness (MLI) is an important indicator for the quality of measles surveillance in countries targeting measles elimination. However, a benchmark rate is still being discussed. We assessed different rates of investigation in 11 territories of the Russian Federation with low reported measles incidence during the previous 4–7 years. Each territory maintained their existing surveillance activities and also undertook additional surveillance activities for MLI over a 3-year period. The annual routine rate of investigation varied from 0·06 to 1·8/100 000 population; the overall rate of investigation, including enhanced surveillance, varied from 1·4 to 7·2/100 000. Forty-nine (30·8%) of 159 measles cases detected were identified through enhanced surveillance. Based on the results of this study, the Russian Federation concluded that a rate of routine investigation of 2/100 000 provided the best balance between available resources and sensitivity for detection of measles cases.
- 1 March 2004
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 137 (3) , 259-261
Spectrum of Anti-Measles Immunoglobulin G Subclasses in Convalescents after Measles
A simple semiquantitative method for measuring anti-measles IgG subclasses is developed on the basis of commercial diagnostic test system for measurements of anti-measles IgG and a kit of...
- 1 March 2004
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 137 (3) , 259-261
Spectrum of Anti-Measles Immunoglobulin G Subclasses in Convalescents after Measles
A simple semiquantitative method for measuring anti-measles IgG subclasses is developed on the basis of commercial diagnostic test system for measurements of anti-measles IgG and a kit of...
- 14 August 1998
- Vol. 43 (3) , 127-9
[Antigenic activity of measles immunostimulating complex].
The liposomal technology for preparing the immunostimulating complex (ISCOM) helped obtain a complex measles preparation whose antigens are represented by the structural proteins of measles virus in the bilayer phosphate-lipid membrane. Immunization of mice with the resultant preparation induced antimeasles antibodies with the maximum titer of antihemagglutinins 1:640 and of antihemolysins 1:1280. The biological activity of antibodies was confirmed in the neutralization test.
- 14 August 1998
- Vol. 43 (3) , 127-9
[Antigenic activity of measles immunostimulating complex].
The liposomal technology for preparing the immunostimulating complex (ISCOM) helped obtain a complex measles preparation whose antigens are represented by the structural proteins of measles virus in the bilayer phosphate-lipid membrane. Immunization of mice with the resultant preparation induced antimeasles antibodies with the maximum titer of antihemagglutinins 1:640 and of antihemolysins 1:1280. The biological activity of antibodies was confirmed in the neutralization test.
- 1 December 1992
- Vol. 36 (6) , 557-66
Wild measles virus strain: isolation and identification.
Four isolates of measles virus (Gag, Il, Buk and Shed) were obtained from suspensions of mononuclear cells from patients at the active stage of the disease. Vero cells were used for the virus isolation. All the isolates caused in the infected cell culture the appearance of symplasts of differently sized, star- or spindle-shaped multinuclear cells. The specificity of cytopathic effect was proved by the adsorption of monkey erythrocytes on the surface of cells infected by virus. The isolates were identified in virus neutralization (VN) and haemagglutination inhibition (HI) tests with different immune preparations: measles-globulin (standard), hyperimmune sera to rubella and mumps viruses, Sch. Zonne and Sch. Flexneria, as well as with conjugates of sera from measles patients and those vaccinated with live measles vaccine (LMV) L-16.
- 1 December 1992
- Vol. 36 (6) , 557-66
Wild measles virus strain: isolation and identification.
Four isolates of measles virus (Gag, Il, Buk and Shed) were obtained from suspensions of mononuclear cells from patients at the active stage of the disease. Vero cells were used for the virus isolation. All the isolates caused in the infected cell culture the appearance of symplasts of differently sized, star- or spindle-shaped multinuclear cells. The specificity of cytopathic effect was proved by the adsorption of monkey erythrocytes on the surface of cells infected by virus. The isolates were identified in virus neutralization (VN) and haemagglutination inhibition (HI) tests with different immune preparations: measles-globulin (standard), hyperimmune sera to rubella and mumps viruses, Sch. Zonne and Sch. Flexneria, as well as with conjugates of sera from measles patients and those vaccinated with live measles vaccine (LMV) L-16.